EKF bears down on costs

EKF bears down on costs

In 2016, management at Aim-listed EKF Diagnostics (EKF) announced plans to simplify the point-of-care services provider with a renewed focus on its diagnostics and laboratory businesses. The strategy seems to be making good progress. Strong revenue growth in the first half across all business areas came alongside a reduction in the cost base, delivering a swing to a £1.4m pre-tax profit.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now